Publications by authors named "F B Magassouba"

Article Synopsis
  • The study aimed to document traditional herbal remedies used to treat malaria in Guinea, collecting data from traditional healers and herbalists between 2008 and 2010.
  • A total of 258 individuals were interviewed, revealing knowledge about malaria symptoms and causes, with 113 plant species identified as remedies, mainly from leaves and stem bark.
  • The research concluded that Guinea's traditional healers possess valuable knowledge of antimalarial plants, suggesting further studies to scientifically validate these remedies and explore their effectiveness.
View Article and Find Full Text PDF

A total of 418 healers have been interviewed in Guinea, a coastal country of West Africa, ranging between 7 degrees 30 and 12 degrees 30 of northern latitude and 8 degrees and 15 degrees of western longitude. Plant species used by the local inhabitants to treat infectious diseases were identified using ethnobotanical, ethnographic and taxonomic methods. During these investigations, 218 plants were registered, of which the following were the most frequently used: Erythrina senegalensis, Bridelia ferruginea, Crossopteryx febrifuga, Ximenia americana, Annona senegalensis, Cochlospermum tinctorium, Cochlospermum planchonii, Lantana camara, Costus afer, Psidium guajava, Terminalia glaucescens, Uapaca somon and Swartzia madagascariensis.

View Article and Find Full Text PDF

From January 1997 to December 2000, 21145 blood donations have been collected and tested for anti-HIV antibodies by the National Center of Blood Transfusion of Conakry (NCBT). 347 were positive, confirmed by Western Blot (312 HIV-1, 20 HIV-2 and 15 HIV1-2). HIV seroprevalence in tested blood donations showed a slow decrease by year: 1.

View Article and Find Full Text PDF

To estimate the risk of transmitting human immunodeficiency virus (HIV) and hepatitis B virus (HBV) by blood transfusion. Residual risks for each of infections have been calculated from incidence cases number, rate incidence for 100,000 person-years has been estimated and multiplied by the period of mute serological window for each agent (22 days for HIV and 56 for HBV) in order to estimate the residual risk. This study shows that risk residual is 1/121 blood donations for HBV and 1/8562 blood donations for HIV.

View Article and Find Full Text PDF